Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress
Kenshi Suzuki(Jikei University School of Medicine), Koji Tsuboi(University of Tsukuba)
Cited by 76
Related Papers
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
|The Lancet Oncology|2020|401